Literature DB >> 30283975

Surgical trends and patient factors associated with the treatment of apical pelvic organ prolapse from a national sample.

Emily A Slopnick1,2, Andrey Petrikovets3, David Sheyn3, Simon P Kim3,4, Carvell T Nguyen5, Adonis K Hijaz3.   

Abstract

INTRODUCTION AND HYPOTHESIS: Prolapse of the vaginal apex can be treated using multiple surgical modalities. We describe national trends and patient characteristics associated with the surgical approach and compare perioperative outcomes of abdominal versus vaginal repair of apical pelvic organ prolapse (POP).
METHODS: The 2006-2012 National Surgical Quality Improvement Program Database was queried for abdominal sacrocolpopexy (ASC) and vaginal apical suspensions. Patients were stratified by whether or not concomitant hysterectomy (CH) was performed or whether or not they were post-hysterectomy (PH). Multivariate logistic regressions were adjusted for confounding variables.
RESULTS: A total of 6,147 patients underwent apical POP repair: 33.9% (2,085) ASCs, 66.1% (4,062) vaginal suspensions. 60.0% (3,689) underwent CH. In all cohorts, older patients were less likely to have ASC (CH: OR 0.48, CI 0.28-0.83, p = 0.008 for age ≥ 60; PH: OR 0.28, CI 0.18-0.43, p < 0.001). Over time, the proportion of all vaginal and abdominal repairs remained relatively stable. Use of minimally invasive ASC, however, increased over the study period (trend p < 0.001), and use of mesh for vaginal suspensions decreased (p < 0.001). ASC had a longer median operative time (PH 174 vs 95 min, p < 0.001; CH 192 vs 127 min, p < 0.001). Complication rates were the same for vaginal repairs and ASC, overall and when sub-stratified by hysterectomy status.
CONCLUSIONS: Nationally, most apical POP repairs are performed via a vaginal route. Older age was predictive of the vaginal route for both CH and PH groups. ASCs had longer operative times. There has been increased utilization of minimally invasive ASC and decreased use of mesh-augmented vaginal suspensions over time.

Entities:  

Keywords:  Gynecologic surgical procedures; Outcome assessment (health care); Pelvic organ prolapse; Urologic surgical procedures

Mesh:

Year:  2018        PMID: 30283975     DOI: 10.1007/s00192-018-3769-1

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  23 in total

1.  Procedures for pelvic organ prolapse in the United States, 1979-1997.

Authors:  Sarah Hamilton Boyles; Anne M Weber; Leslie Meyn
Journal:  Am J Obstet Gynecol       Date:  2003-01       Impact factor: 8.661

2.  Management of apical compartment prolapse (uterine and vault prolapse): A FIGO Working Group report.

Authors:  Cornelia Betschart; Mauro Cervigni; Oscar Contreras Ortiz; Stergios K Doumouchtsis; Masayasu Koyama; Carlos Medina; Jorge Milhem Haddad; Filippo la Torre; Giuliano Zanni
Journal:  Neurourol Urodyn       Date:  2015-10-20       Impact factor: 2.696

3.  Practical considerations on the use of the Charlson comorbidity index with administrative data bases.

Authors:  W D'Hoore; A Bouckaert; C Tilquin
Journal:  J Clin Epidemiol       Date:  1996-12       Impact factor: 6.437

4.  Postoperative Pulmonary Complications, Early Mortality, and Hospital Stay Following Noncardiothoracic Surgery: A Multicenter Study by the Perioperative Research Network Investigators.

Authors:  Ana Fernandez-Bustamante; Gyorgy Frendl; Juraj Sprung; Daryl J Kor; Bala Subramaniam; Ricardo Martinez Ruiz; Jae-Woo Lee; William G Henderson; Angela Moss; Nitin Mehdiratta; Megan M Colwell; Karsten Bartels; Kerstin Kolodzie; Jadelis Giquel; Marcos Francisco Vidal Melo
Journal:  JAMA Surg       Date:  2017-02-01       Impact factor: 14.766

5.  Trends in management of pelvic organ prolapse among female Medicare beneficiaries.

Authors:  Aqsa A Khan; Karyn S Eilber; J Quentin Clemens; Ning Wu; Chris L Pashos; Jennifer T Anger
Journal:  Am J Obstet Gynecol       Date:  2014-10-19       Impact factor: 8.661

Review 6.  Epidemiology and prevalence of pelvic organ prolapse.

Authors:  Denise Chow; Larissa V Rodríguez
Journal:  Curr Opin Urol       Date:  2013-07       Impact factor: 2.309

7.  Rates of colpopexy and colporrhaphy at the time of hysterectomy for prolapse.

Authors:  Pamela S Fairchild; Neil S Kamdar; Mitchell B Berger; Daniel M Morgan
Journal:  Am J Obstet Gynecol       Date:  2015-09-11       Impact factor: 8.661

Review 8.  Surgical management of pelvic organ prolapse in women.

Authors:  Christopher Maher; Benjamin Feiner; Kaven Baessler; Corina Schmid
Journal:  Cochrane Database Syst Rev       Date:  2013-04-30

9.  Symptomatic pelvic organ prolapse: prevalence and risk factors in a population-based, racially diverse cohort.

Authors:  Guri Rortveit; Jeanette S Brown; David H Thom; Stephen K Van Den Eeden; Jennifer M Creasman; Leslee L Subak
Journal:  Obstet Gynecol       Date:  2007-06       Impact factor: 7.661

10.  The UK National Prolapse Survey: 10 years on.

Authors:  Swati Jha; Alfred Cutner; Paul Moran
Journal:  Int Urogynecol J       Date:  2017-09-15       Impact factor: 2.894

View more
  4 in total

1.  Trends in apical prolapse surgery between 2010 and 2016 in Denmark.

Authors:  Karen Ruben Husby; Gunnar Lose; Niels Klarskov
Journal:  Int Urogynecol J       Date:  2019-01-04       Impact factor: 2.894

2.  The resurrection of sacrospinous fixation: unilateral apical sling hysteropexy.

Authors:  Dmitry Shkarupa; Nikita Kubin; Ekaterina Shapovalova; Anastasya Zaytseva
Journal:  Int Urogynecol J       Date:  2019-06-10       Impact factor: 2.894

Review 3.  Abdominal and vaginal pelvic support with concomitant hysterectomy for uterovaginal pelvic prolapse: a comparative systematic review and meta-analysis.

Authors:  Anood Alfahmy; Amr Mahran; Britt Conroy; Rosemary R Brewka; Mostafa Ibrahim; David Sheyn; Sherif A El-Nashar; Adonis Hijaz
Journal:  Int Urogynecol J       Date:  2021-05-29       Impact factor: 2.894

Review 4.  Robotic-assisted repair of pelvic organ prolapse: a scoping review of the literature.

Authors:  Jeffrey S Schachar; Catherine A Matthews
Journal:  Transl Androl Urol       Date:  2020-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.